Success Stories: NAILG Supported an Associate Research Scientist in the Field of Biochemistry in Securing an NIW Petition Approval

Client’s Testimonial:

“This is wonderful news! Thank you so much for letting me know!”

On July 19^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: Germany

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: July 19^th, 2023

Processing Time: 29 days (Premium Processing Requested)

Case Summary:

A distinguished biochemist specializing in epigenetics approached our legal team for assistance with his National Interest Waiver (NIW) petition. We conducted a thorough assessment of his academic credentials and research achievements, verifying the depth and significance of his contributions to genetic disease research. Confident in the importance of his work, we proceeded with the retainer agreement to secure his NIW approval.

Our client’s research is dedicated to unraveling the structural basis of epigenetic modifiers, paving the way for innovative therapeutic interventions for genetic disorders. His key contributions include:

Authorship of 14 peer-reviewed journal articles, with one as the first author and two as co-first author.
A total of 1,097 citations reflects the broad recognition and influence of his research.
Significant funding support from leading institutions, including the National Institutes of Health (NIH), the United Kingdom’s Biotechnology and Biological Sciences Research Council (BBSRC), and the State of São Paulo Research Foundation (FAPESP), among others.

One of the most impactful areas of his research involves the biochemical and structural characterization of recombinant proteins, which is essential for understanding gene regulation and disease mechanisms. His findings contribute to the development of diagnostic tools for conditions associated with abnormal DNA methylation patterns, ultimately advancing precision medicine and personalized treatment strategies.

His work has significantly deepened our understanding of epigenetic regulation, with far-reaching implications for the development of novel therapeutic approaches. Given his impressive track record and continued dedication, it is evident that he will remain at the forefront of biomedical advancements.

He even received 4 letters of recommendation from fellow experts, one of the excerpts is mentioned below:

“To conclude, [client] is a major player in the biotechnologies field, and I propose an innovative investigator with strong expertise in biotechnology. His mastery of both classic biochemical techniques and modern, state-of-the-art approaches for genomics, transcriptomics, and proteomics analysis makes him a significant asset to the United States. I acknowledge that he is an advantage in the maintenance of the country’s global leadership. Thank you.”

Through our meticulous and strategic case preparation, we effectively demonstrated the national significance of the client’s research, leading to his successful NIW approval. His achievements underscore the transformative impact of scientific innovation on healthcare, and we are honored to have played a role in his journey. We look forward to witnessing his ongoing contributions to biomedical science and epigenetics.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.